Abstract

The Broader Importance of Flow Chemistry to Manufacture of Pharmaceuticals

Andrew Rutter, Senior Director, GlaxoSmithKline

Flow chemistry’s importance to medicines manufacture goes far beyond enabling different (better) chemistry – it is about providing agility (and compliance) in how we design and build medicines supply chains. I will explore how flow chemistry builds to Continuous Manufacturing processes and how this approach supports agility in the supply of medicines. I will link this approach to advances in modularization and a digital twin of the process. This philosophy is equally applicable in Small and Large Molecule manufacture.